![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
20
Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Celecoxib, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2014-340 - Rev 00
This Chemical Type CEP, issued on September 09, 2016, remains in force until November 21, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 2591 associated with this CEP further emphasizes